ArticleThe Journal of clinical investigation2023

Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer.

Peter Zanvit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.